Xinbao Hao

2.4k total citations · 1 hit paper
35 papers, 1.8k citations indexed

About

Xinbao Hao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xinbao Hao has authored 35 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Xinbao Hao's work include RNA modifications and cancer (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Virus-based gene therapy research (3 papers). Xinbao Hao is often cited by papers focused on RNA modifications and cancer (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Virus-based gene therapy research (3 papers). Xinbao Hao collaborates with scholars based in China, United States and Bangladesh. Xinbao Hao's co-authors include Liang Xu, Qing Ji, Min Zhang, Daiming Fan, Yang Meng, Jeffrey DeSano, Wenhua Tang, Theodore S. Lawrence, Ling Li and Eric R. Fearon and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Xinbao Hao

35 papers receiving 1.8k citations

Hit Papers

MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-In... 2009 2026 2014 2020 2009 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
    2009 558 citations Qing Ji, Xinbao Hao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinbao Hao China 14 1.3k 835 506 129 124 35 1.8k
Jun Song China 23 990 0.8× 675 0.8× 449 0.9× 105 0.8× 138 1.1× 69 1.6k
Chandramu Chetty United States 24 923 0.7× 730 0.9× 451 0.9× 91 0.7× 115 0.9× 32 1.6k
Alina Molchadsky Israel 21 1.3k 1.0× 518 0.6× 797 1.6× 107 0.8× 70 0.6× 28 1.8k
Wenfeng Cao China 22 947 0.7× 456 0.5× 396 0.8× 147 1.1× 102 0.8× 59 1.6k
Huizhen Zhang China 20 1.4k 1.1× 864 1.0× 236 0.5× 85 0.7× 141 1.1× 40 1.9k
Giuseppina De Petro Italy 25 1.1k 0.8× 1.0k 1.2× 236 0.5× 115 0.9× 83 0.7× 65 1.8k
Markus Kaller Germany 17 1.4k 1.1× 1.1k 1.4× 650 1.3× 137 1.1× 75 0.6× 28 2.0k
Alexandra Avgustinova Spain 10 1.2k 0.9× 919 1.1× 532 1.1× 86 0.7× 88 0.7× 13 1.9k
Yiji Liao China 19 1.2k 0.9× 699 0.8× 285 0.6× 101 0.8× 80 0.6× 28 1.6k

Countries citing papers authored by Xinbao Hao

Since Specialization
Citations

This map shows the geographic impact of Xinbao Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinbao Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinbao Hao more than expected).

Fields of papers citing papers by Xinbao Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinbao Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinbao Hao. The network helps show where Xinbao Hao may publish in the future.

Co-authorship network of co-authors of Xinbao Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Xinbao Hao. A scholar is included among the top collaborators of Xinbao Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinbao Hao. Xinbao Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jingyi, Xiuli Du, Tian Zhao, et al.. (2025). In vivo FAP-CAR macrophages enhance chemotherapy and immunotherapy against pancreatic cancer by removing the fibrosis barrier. Journal of Controlled Release. 384. 113888–113888. 10 indexed citations
2.
Yang, Xin, Xiangyu Wu, Xinbao Hao, et al.. (2025). Unleashing the therapeutic potential of tumor-draining lymph nodes: spotlight on bladder cancer. Journal of Translational Medicine. 23(1). 489–489. 1 indexed citations
3.
Wu, Jiao, Xing Cheng, Xinbao Hao, et al.. (2025). Metabolic profiling and evaluation of antioxidant and anti-inflammatory properties of Apis cerana cerana Honey from Sansha City, Hainan Province, China. Food Chemistry. 475. 143256–143256. 1 indexed citations
4.
Bi, Chengfeng, Yuhua Huang, Fang Wang, et al.. (2024). MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implications. Haematologica. 109(9). 2810–2821. 1 indexed citations
5.
Li, Xiaoyu, Pei Shu, Diyuan Qin, et al.. (2023). First-in-human, phase I study of KC1036, a multiple kinase inhibitor, as a single agent in patients with advanced solid tumors.. Journal of Clinical Oncology. 41(16_suppl). e15000–e15000. 1 indexed citations
6.
Zhang, Qi, Zhe Yang, Xinbao Hao, et al.. (2023). Niclosamide improves cancer immunotherapy by modulating RNA-binding protein HuR-mediated PD-L1 signaling. Cell & Bioscience. 13(1). 192–192. 13 indexed citations
7.
Yang, Zhe, Qi Zhang, Xiaoqing Wu, et al.. (2023). Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147. Biomedicines. 11(7). 2019–2019. 6 indexed citations
8.
Zhang, Xuan, Chengfeng Bi, Weiwei Zhang, et al.. (2019). Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas. Leukemia. 34(1). 138–150. 24 indexed citations
9.
10.
Zeng, Jiangzheng, et al.. (2015). Clinical efficacy of metronomic chemotherapy after cool-tip radiofrequency ablation in the treatment of hepatocellular carcinoma. International Journal of Hyperthermia. 32(2). 193–198. 13 indexed citations
11.
12.
Li, Ling, Wenhua Tang, Xiaoqing Wu, et al.. (2013). HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s. Clinical Cancer Research. 19(24). 6703–6715. 57 indexed citations
13.
Lu, Dongdong, Yinyuan Wu, Yinyin Wang, et al.. (2012). CREPT Accelerates Tumorigenesis by Regulating the Transcription of Cell-Cycle-Related Genes. Cancer Cell. 21(1). 92–104. 75 indexed citations
14.
Hao, Xinbao, Yinyin Wang, Fangli Ren, et al.. (2011). SNX25 regulates TGF-β signaling by enhancing the receptor degradation. Cellular Signalling. 23(5). 935–946. 46 indexed citations
15.
Wang, Wei, Lijun Huang, Qiuling Ma, et al.. (2011). Homozygous intronic mutation leading to inefficient transcription combined with a novel frameshift mutation in F13A1 gene causes FXIII deficiency. Journal of Human Genetics. 56(6). 460–463. 8 indexed citations
16.
Jia, Lijun, Jie Yang, Xinbao Hao, et al.. (2010). Validation of SAG/RBX2/ROC2 E3 Ubiquitin Ligase as an Anticancer and Radiosensitizing Target. Clinical Cancer Research. 16(3). 814–824. 81 indexed citations
17.
Jia, Li, Caroline Romestaing, Xianlin Han, et al.. (2010). Cardiolipin Remodeling by ALCAT1 Links Oxidative Stress and Mitochondrial Dysfunction to Obesity. Cell Metabolism. 12(2). 154–165. 234 indexed citations
18.
Nie, Jia, Xinbao Hao, Daohong Chen, et al.. (2009). A novel function of the human CLS1 in phosphatidylglycerol synthesis and remodeling. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1801(4). 438–445. 20 indexed citations
19.
Ji, Qing, Xinbao Hao, Yang Meng, et al.. (2008). Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer. 8(1). 266–266. 338 indexed citations
20.
Xu, Liang, Yao Dai, Yang Meng, et al.. (2007). Molecular radiosensitization of prostate cancer by modulating cell death pathways. Molecular Cancer Therapeutics. 6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Song Breakdown of academic impact, for papers by Chandramu Chetty Breakdown of academic impact, for papers by Alina Molchadsky Breakdown of academic impact, for papers by Wenfeng Cao Breakdown of academic impact, for papers by Huizhen Zhang Breakdown of academic impact, for papers by Giuseppina De Petro Breakdown of academic impact, for papers by Markus Kaller Breakdown of academic impact, for papers by Alexandra Avgustinova Breakdown of academic impact, for papers by Yiji Liao
Rankless by CCL
2026